Imperagen Raises £5 Million To Use Quantum Physics, AI On Enzyme Engineering

Imperagen Raises £5 Million To Use Quantum Physics, AI On Enzyme Engineering

Imperagen raises £5 million is making waves in biotech as the startup unveils a powerful fusion of quantum physics, artificial intelligence, and robotics to transform enzyme engineering. If you are searching for what Imperagen does, how its technology works, or why investors are betting on AI-driven biotech, the answer lies in its mission to replace slow, trial-and-error enzyme development with faster, computer-guided discovery. The company believes this shift could reshape pharmaceuticals, industrial chemistry, and sustainable manufacturing. At its core, Imperagen is targeting one of the most complex problems in modern science: designing enzymes that reliably perform specific chemical reactions. These enzymes are essential in drug development, food production, agriculture, and biofuels. By accelerating how enzymes are engineered, the company aims to reduce costs, shorten development timelines, and unlock new possibilities for bio-based industries. Quantum AI Enzyme Engineering Takes Ce…